"GLP-1 medications like Ozempic, Wegovy and Mounjaro have become something of a cultural lightning rod over the past few years - originally developed to treat Type 2 diabetes, these weekly injections work by mimicking a hormone that regulates blood sugar and appetite, leading to significant weight loss in many users."
""She was not prescribed by her doctor and is not diabetic, nor was she obese," they began. "She decided to go on the drug after her weight loss began plateauing." However, what began as a solution to break through that plateau has evolved into something far more complicated, affecting her finances, physical health, and their relationship."
""Now, with the drug in full effect, she's upset that her butt is flat, frustrated that her skin is wrinkly and looks gaunt - which the original poster has admitted affects their sex life." Her doctor has confirmed that she's lost muscle mass. She no longer goes to the gym."
""And because she's been paying out of pocket for the drug, she's gone from putting a bit of money in savings each month to debt, playing 'whack-a-mole with bills,' despite making six figures." Though the original poster feels like Ozempic has resulted in a net negative after two years, their partner remains intent on staying on the drug."
GLP-1 medications such as Ozempic, Wegovy, and Mounjaro mimic a hormone that regulates blood sugar and appetite, often leading to significant weight loss. They have become widely used beyond medical necessity due to celebrity influence, social media trends, and telehealth access. A reported case describes a partner who used Ozempic without diabetes or obesity after weight loss plateaued. Over two years, the partner experienced flat butt appearance, wrinkly and gaunt skin, and confirmed muscle loss by a doctor. Gym attendance stopped, and sex life was affected. The out-of-pocket cost contributed to debt despite high income, while the partner remained determined to continue the medication.
Read at HuffPost
Unable to calculate read time
Collection
[
|
...
]